Stock listing
OCS Stock Price, News, Filings & Events — Oculis Holding Ag
Selected listing: OCS · NASDAQ · USD · US
This page tracks Oculis Holding Ag's OCS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCS:NASDAQ. OCS:NASDAQ is the stock-level entry point for investors researching Oculis Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oculis Holding AG is a public company traded under the ticker OCS in the American market. With a market capitalization of approximately $636.3 million, the company focuses on developing innovative ophthalmic therapies. Oculis aims to address unmet medical needs in eye care through its advanced drug delivery systems and formulations.
- Ticker
- OCS:NASDAQ
- Asset type
- Stock
- Market cap
- $650.4M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
Oculis Holding Ag OCS:NASDAQ stock context
This page tracks Oculis Holding Ag's OCS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCS:NASDAQ. OCS:NASDAQ is the stock-level entry point for investors researching Oculis Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oculis Holding AG is a public company traded under the ticker OCS in the American market. With a market capitalization of approximately $636.3 million, the company focuses on developing innovative ophthalmic therapies. Oculis aims to address unmet medical needs in eye care through its advanced drug delivery systems and formulations.
Latest news from Oculis Holding Ag
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
August 24, 2026
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emergin...
August 10, 2026
Oculis Reports Q2 2026 Financial Results and Provides Company Update
August 6, 2026
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Rela...
August 3, 2026
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
July 2, 2026
Research Oculis Holding Ag
Oculis Holding Ag investor report
Review AI stock analysis and investor report context for OCS:NASDAQ.
Oculis Holding Ag company profile
View the public company page for Oculis Holding Ag on 6ix.
Oculis Holding Ag news
Read company news and market updates connected to Oculis Holding Ag.
Oculis Holding Ag investor events
Find investor webinars, events, and replay context for Oculis Holding Ag.
Alternate listings
OCS:OMXICE
IS · ISK
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.
A3D8QG:LSX
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.
A3D8QG:LS
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.
CR5:SWB
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.
CR5:FWB
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.
OCS:BOATS
US · USD
Alternate listing for Oculis Holding Ag; the primary context on this page is OCS:NASDAQ.